Literature DB >> 3282955

Is insulin atherogenic?

R J Jarrett1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3282955     DOI： 10.1007/bf00395550

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  45 in total

1.  PLASMA-INSULIN CONCENTRATIONS AFTER MYOCARDIAL INFRACTION.

Authors:  N PETERS; C N HALES
Journal:  Lancet       Date:  1965-05-29       Impact factor: 79.321

2.  Serum-insulin in essential hypertension and in peripheral vascular disease.

Authors:  T A Welborn; A Breckenridge; A H Rubinstein; C T Dollery; T R Fraser
Journal:  Lancet       Date:  1966-06-18       Impact factor: 79.321

3.  Diabetes in the Seneca Indians. Plasma insulin responses to oral carbohydrate.

Authors:  L A Frohman; T D Doeblin; F G Emerling
Journal:  Diabetes       Date:  1969-01       Impact factor: 9.461

4.  Serum insulin concentrations and anticipatory factors of cardiomyopathy in NIDDM.

Authors:  T D Hockaday
Journal:  Diabete Metab       Date:  1987-07

5.  Hyperinsulinemia--a link between glucose intolerance, obesity, hypertension, dyslipoproteinemia, elevated serum uric acid and internal cation imbalance.

Authors:  M Modan; H Halkin; Z Fuchs; A Lusky; A Chetrit; P Segal; A Eshkol; S Almog; M Shefi
Journal:  Diabete Metab       Date:  1987-07

6.  The Bedford survey: ten year mortality rates in newly diagnosed diabetics, borderline diabetics and normoglycaemic controls and risk indices for coronary heart disease in borderline diabetics.

Authors:  R J Jarrett; P McCartney; H Keen
Journal:  Diabetologia       Date:  1982-02       Impact factor: 10.122

7.  Macrovascular complications in relation to hyperinsulinaemia in non-insulin-dependent diabetes mellitus.

Authors:  K Pyörälä; M Uusitupa; M Laakso; O Siitonen; L Niskanen; T Rönnemaa
Journal:  Diabete Metab       Date:  1987-07

8.  Daily insulin dose as a predictor of macrovascular disease in insulin treated non-insulin-dependent diabetics.

Authors:  H U Janka; A G Ziegler; E Standl; H Mehnert
Journal:  Diabete Metab       Date:  1987-07

9.  Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations.

Authors:  T A Welborn; K Wearne
Journal:  Diabetes Care       Date:  1979 Mar-Apr       Impact factor: 19.112

10.  Is the relationship between blood pressure and cardiovascular risk dependent on body mass index?

Authors:  F Cambien; J M Chretien; P Ducimetiere; L Guize; J L Richard
Journal:  Am J Epidemiol       Date:  1985-09       Impact factor: 4.897
View more
  17 in total

Review 1.  Enhancing insulin action: from chemical elements to thiazolidinediones.

Authors:  R Perfetti; K Chamie
Journal:  J Endocrinol Invest       Date:  2001-04       Impact factor: 4.256

Review 2.  Coronary heart disease in diabetes mellitus--antecedents and associations.

Authors:  P H Winocour
Journal:  Postgrad Med J       Date:  1991-10       Impact factor: 2.401

3.  Is insulin atherogenic?

Authors:  T J Orchard
Journal:  Diabetologia       Date:  1988-06       Impact factor: 10.122

Review 4.  Lipoprotein alterations in diabetes mellitus.

Authors:  G M Kostner; I Karádi
Journal:  Diabetologia       Date:  1988-10       Impact factor: 10.122

5.  Disturbances of insulin in British Asian and white men.

Authors:  P M McKeigue
Journal:  BMJ       Date:  1989-11-04

Review 6.  [Normoglycemia as a therapy goal in diabetes treatment--concept and realization].

Authors:  E G Siegel
Journal:  Klin Wochenschr       Date:  1990-03-16

7.  Consequences of systemic venous drainage and denervation of heterotopic pancreatic transplants for insulin/C-peptide profiles in the basal state and after oral glucose.

Authors:  M Nauck; M Büsing; E G Siegel; J Talartschik; A Baartz; T Baartz; U T Hopt; H D Becker; W Creutzfeldt
Journal:  Diabetologia       Date:  1991-08       Impact factor: 10.122

8.  Metabolic and hormonal studies of type 1 (insulin-dependent) diabetic patients after successful pancreas and kidney transplantation.

Authors:  R Landgraf; J Nusser; R L Riepl; F Fiedler; W D Illner; D Abendroth; W Land
Journal:  Diabetologia       Date:  1991-08       Impact factor: 10.122

Review 9.  Prevention of complications in non-insulin-dependent diabetes mellitus (NIDDM).

Authors:  B H Wolffenbuttel; T W van Haeften
Journal:  Drugs       Date:  1995-08       Impact factor: 9.546

10.  Insulin in ischaemic heart disease: are associations explained by triglyceride concentrations? The Caerphilly prospective study.

Authors:  J W Yarnell; P M Sweetnam; V Marks; J D Teale; C H Bolton
Journal:  Br Heart J       Date:  1994-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.